Beam Therapeutics Inc (BEAM)
22.71
+0.97
(+4.46%)
USD |
NASDAQ |
May 02, 16:00
22.71
0.00 (0.00%)
After-Hours: 18:18
Beam Therapeutics Accounts Payable (Quarterly): 1.617M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.617M |
September 30, 2023 | 3.177M |
June 30, 2023 | 6.886M |
March 31, 2023 | 14.06M |
December 31, 2022 | 9.029M |
September 30, 2022 | 7.024M |
June 30, 2022 | 7.095M |
March 31, 2022 | 6.266M |
December 31, 2021 | 7.474M |
September 30, 2021 | 7.282M |
Date | Value |
---|---|
June 30, 2021 | 8.03M |
March 31, 2021 | 7.983M |
December 31, 2020 | 6.314M |
September 30, 2020 | 6.569M |
June 30, 2020 | 6.154M |
March 31, 2020 | 6.101M |
December 31, 2019 | 7.846M |
September 30, 2019 | 3.857M |
June 30, 2019 | 3.587M |
December 31, 2018 | 7.351M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.617M
Minimum
Dec 2023
14.06M
Maximum
Mar 2023
6.650M
Average
6.886M
Median
Jun 2023
Accounts Payable (Quarterly) Benchmarks
Eli Lilly and Co | 2.474B |
Moderna Inc | 520.00M |
Pfizer Inc | 6.71B |
Editas Medicine Inc | 8.269M |
Intellia Therapeutics Inc | 7.452M |